Pulmonary function decline in amyotrophic lateral sclerosis

Nursing and Health Professions

• Forced Vital Capacity 83%
• Medicare 50%
• Maximal Expiratory Pressure 50%
• Deterioration 33%
• Lung Clearance 33%
• Pressure 33%
• Muscle Strength 33%
• Measurement 16%
• Time 16%
• Procedures 16%
• Amyotrophic Lateral Sclerosis 16%
• Ethinylestradiol Plus Megestrol Acetate 16%
• Maximal Inspiratory Pressure 16%
• Maximal Voluntary Ventilation 16%

Medicine and Dentistry

• Deterioration 100%
• Forced Vital Capacity 83%
• Lung Function 66%
• Muscle Strength 33%
• Lung Clearance 33%
• Measurement 16%
• Amyotrophic Lateral Sclerosis 16%
• Sitting 16%
• Respiratory Muscle 16%
• Maximal Voluntary Ventilation 16%
• Ethinylestradiol Plus Megestrol Acetate 16%
• Mouth 16%